Personalized Management in Low-Risk Prostate Cancer: The Role of Biomarkers
Current criteria to predict low-risk prostate cancer (PCa) are still subject to discussion as a substantial number of PCa patients who progress to a more aggressive disease seem to be missed, using these criteria. The main challenge in PCa diagnosis, therefore, is to distinguish patients with low-ri...
Saved in:
Main Authors: | Siebren Dijkstra, Agus Rizal A. H. Hamid, Gisèle H. J. M. Leyten, Jack A. Schalken |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2012/327104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01) -
Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer
by: Kevin S. Choe, et al.
Published: (2010-01-01) -
The Role of Targeted Focal Therapy in the Management of Low-Risk Prostate Cancer: Update on Current Challenges
by: Daniel W. Smith, et al.
Published: (2012-01-01) -
Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
by: Pim J. van Leeuwen, et al.
Published: (2016-01-01) -
Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
by: Wei Jin, et al.
Published: (2020-01-01)